“Global Hyperpigmentation Treatment Market to reach a market value of USD 9.3 Billion by 2030 growing at a CAGR of 8.2%”
The Global Hyperpigmentation Treatment Market size is expected to reach $9.3 billion by 2030, rising at a market growth of 8.2% CAGR during the forecast period.
There is a notable increase in awareness about skincare practices among the population in Mexico. The Mexican population has a growing cosmetic consciousness, with individuals expressing a desire for clear and even-toned skin. Consequently, the North America region would generate a revenue of USD 1,818.2 Million in 2022. The high prevalence of hyperpigmentation in North America creates a substantial demand for effective treatment solutions. North America boasts advanced healthcare infrastructure, including well-equipped dermatological clinics and hospitals.
Social media platforms amplify skincare trends and routines, including Instagram, TikTok, and YouTube. Influencers and skincare enthusiasts showcase their hyperpigmentation treatment journeys, fostering awareness and inspiring others to explore similar interventions. Therefore, the hyperpigmentation treatment market is expanding significantly due to the social media influence and beauty standards.
Additionally, Individuals with a higher disposable income can afford professional hyperpigmentation treatments dermatologists and skincare professionals offer. This includes procedures such as laser therapy, chemical peels, and other advanced interventions. Thus, because of the higher level of disposable income, the market is anticipated to increase significantly.
However, Affordability challenges may contribute to disparities in treatment access across different demographics and socioeconomic groups. This can lead to unequal distribution of hyperpigmentation treatment benefits. Disparities in treatment access create challenges for achieving inclusive market growth, as certain population segments may be underserved or excluded due to financial constraints. Thus, high treatment costs can slow down the growth of the market.
Furthermore, Lockdowns, restrictions, and temporary closures of production facilities led to interruptions in the supply of raw materials and finished products. This disruption resulted in delays in the production and distribution of hyperpigmentation treatment products, affecting the availability of certain formulations, topical agents, and devices in the market. Thus, the COVID-19 pandemic had a moderate effect on the market.
By treatment type, the market is categorized into topical agent, photo therapy, and microdermabrasion. In 2022, the topical agent segment held a 44.40 % revenue share in the market. Topical agents offer a non-invasive treatment option, eliminating the need for surgical procedures or more aggressive interventions. The non-invasive nature of topical treatments appeals to individuals who prefer less downtime and minimal discomfort. This characteristic contributes to the widespread adoption of the topical agent segment in the hyperpigmentation treatment market.
On the basis of end user, the market is divided into hospitals, dermatological clinics, and others. The hospitals segment garnered a 40.6 % revenue share in the market in 2022. Hospitals often house advanced dermatological departments equipped with state-of-the-art technologies and skilled healthcare professionals. These facilities offer comprehensive services for diagnosing and treating various skin conditions, including hyperpigmentation.
Based on disorder type, the market is classified into age spot, melasma, and other. In 2022, the melasma segment witnessed a 47.81 % revenue share in the market. Melasma is a common pigmentary disorder, and its prevalence has steadily increased. Factors like hormonal changes, genetic predisposition, and sun exposure contribute to the rising incidence of melasma. Melasma is often hormonally mediated and is commonly associated with pregnancy, oral contraceptive use, and hormonal therapies. The condition predominantly affects women, particularly those in their reproductive years.
Free Valuable Insights: Global Hyperpigmentation Treatment Market size to reach USD 9.3 Billion by 2030
Region-wise, the treatment market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired a 28.57 % revenue share in the treatment market. There is a growing awareness of skincare practices and a shift towards proactive skin health management in the Asia Pacific. Adopting Western beauty standards has influenced skincare preferences in the Asia Pacific region. The increasing emphasis on aesthetics and appearance enhancement drives the demand for cosmetic procedures in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 5 Billion |
| Market size forecast in 2030 | USD 9.3 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 8.2% from 2023 to 2030 |
| Number of Pages | 223 |
| Number of Tables | 350 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Treatment Type, Disorder Type, End User, Region |
| Country scope |
|
| Companies Included | Vivier Pharma Inc., Pierre Fabre S.A, Aerolase, L'Oréal S.A., CP Skin Health Group, Inc. (The Colgate Palmolive Company), Trophy Skin Products LLC, The Alchemee LLC (Taro Pharmaceutical Industries Ltd.) Episciences, Inc., The Procter and Gamble Company, Galderma S.A. |
By Treatment Type
By End User
By Disorder Type
By Geography
This Market size is expected to reach $9.3 billion by 2030.
Social Media Influence And Beauty Standards are driving the Market in coming years, however, High Cost Of Hyperpigmentation Treatment restraints the growth of the Market.
Vivier Pharma Inc., Pierre Fabre S.A, Aerolase, L'Oréal S.A., CP Skin Health Group, Inc. (The Colgate Palmolive Company), Trophy Skin Products LLC, The Alchemee LLC (Taro Pharmaceutical Industries Ltd.) Episciences, Inc., The Procter and Gamble Company, Galderma S.A.
The expected CAGR of this Market is 8.2% from 2023 to 2030.
The Dermatological Clinics segment is leading the Market by End User in 2022 there by, achieving a market value of $4.5 billion by 2030.
The North America region dominated the Market by Region in 2022, and would continue to be a dominant market till 2030; there by, achieving a market value of $3.2 billion by 2030.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 